期刊文献+

氯沙坦与福辛普利、卡托普利对老年高血压患者肾功能保护的对比临床研究 被引量:6

A Comparison Between The Effects of Losartan and Fosinopril,Captopril on The Excretive Rate of Urinary Albumin and The Clearance of Endogenous Creatinine in Elderly Hypertensive Patients
下载PDF
导出
摘要 目的观察氯沙坦和与福辛普利、卡托普利对老年高血压病人尿白蛋白排泄量(UAER)与内生肌酐清除率(CrC)的影响,比较3种药物对老年高血压患者肾功能保护作用的差别。方法选择162例老年高血压病2~3级患者,UAER在20~400mg/24h。CrC在31~51mL/min1.73m-2之间,按序数分成均等3组:氯沙坦组、福辛普利组、卡托普利组,平均3周。进行治疗前后肾功能保护作用对比研究。结果氯沙坦治疗老年人高血压病的临床效果同福辛普利以及卡托普利一样有效,3种药物降压总有效率分别为94%、93%、93%(P>0.05)。但氯沙坦与福辛普利对老年高血压患者肾功能保护作用明显好于卡托普利,3组比较有显著差异性。结论氯沙坦除有良好的降压作用外,尚具有更好地保护老年高血压患者肾功能作用。 ObjectiveTo evaluate the effects of losartan, fosinopril and captopril on the excretive rate of urinary albumin(UAER) and the clearance of endogenous creatinine (Cr-C) in elderly hypertension patients.MethodsIn this study, 162 elderly patients with 2~3 grade hypertension were enrolled.The patients were divided into 3 groups which treated with losartan (mean dosage 240 mg/d, n=54) and the fosinopril (248 mg/d, n=54) , and captopril (245 mg/d, n=54) for average three weeks.The anti-hypertensive effect and UAER and Cr-C were determined before and after the treatment. ResultsThe response rates were 94% in losartan group and 93%, 93% in fosinopril group, captopril group(P>0.05).Rate of decrease of UAER were 89% in Losartan group which was much better than that of 59% and 50% in fosinopril group and captopril group (P<0.01).Rate of Cr-C improvement was 94% in losartan group better than 78% in fosinopril group and 63% in captopril group.ConclusionAlthough no difference in the antihypertensive respone rate was found in the losartan, fosinopril, and captopril groups.Losartan has been shown obviously better effects on UAER and Cr-C than that by captopril and fosinopril in elderly hypertension patient.
出处 《高血压杂志》 CSCD 北大核心 2005年第5期269-272,共4页 Chinese Journal of Hypertension
关键词 氯沙坦 福辛普利 卡托普利 老年人 高血压 肾功能保护 对比研究 Losartan Fosinpril Captopril The elderly Renal function
  • 相关文献

参考文献11

  • 1戚仁锋 王淑娟 许国楦.诊断学[M]:第三版[M].北京人民卫生出版社,1992.366-367.
  • 2Goldberg MR, De Mey C,Wroblewski JM, et al. Differential effects of oral Losartan and enalapril on local venous and systemic pressor responses to angiotenainⅠand Ⅱ in healthy men[J]. Clin Pharmacol Ther, 1996,59:72.
  • 3Weber MA, Byyny RL, Pratt JH, et al. Blood pressure effects of the angiotensin Ⅱ receptor blocker, Losartan [J]. West J Med,1998,168:272.
  • 4Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of Losartan potassium, an angiotensin Ⅱ receptor antagonist,compared with hydrochlorothiazide, atenolol, felodipine ER,and angiotensin-coverting enzyme inhibitors for the treatment ofsystemic hypertension[J]. Am J Cardiol, 1995,72:793.
  • 5Goldberg MR, Bradstreet TE,Mcwilliams EJ, et al. Biochemical effects of Losartan, a nonpeptide angiotensin Ⅱ receptor antagonist, on the renin-angiotensin aldosterone system in hypertensive patients[J]. Hypertension, 1995,25:37.
  • 6Shaw W, Snavely D. Safets and efficacy of losartan (DUP753,MK954) in hypertensive patient with renal impairment[J]. JAm Soc Nephrol,1994,5:567.
  • 7Hamdan AD, Quist WC, Gagne JB, et al. Angiotensin-Converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta[J]. Circulation, 1996,93:1073-1078.
  • 8Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability oflosartan compared with atenolol,felodipine and angiotensin coverring enzyme inhibitors[J]. J Hypertens, 1995,13:S77-80.
  • 9Chan JC, Critehley JA, Lappe JT, et al. Randomised, doubleblind, parallel study of the anti-hypertensive efficacy and safetyof losartan potassium compared with felodipine Erin elderly patients with mild to moderate hypertension[J]. J Hum Hypertens,1995,9:765.
  • 10季洪赞,段苏友,冯根宝,胡兰萍,缪东培,许莲娥,胡拥军,商玮,李琳.血管紧张素转化酶基因插入/缺失多态性与老年糖耐量低减合并冠心病相关性研究[J].中国老年学杂志,2001,21(5):328-330. 被引量:6

二级参考文献2

  • 1Pan X R,Diabetes Care,1997年,20卷,537页
  • 2Stenven A G,JAMA,1995年,274卷,801页

共引文献5

同被引文献68

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部